Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Clidinium
2. Clidinium Iodide
3. Clidinium Iodide, (+-)-isomer
4. Clidinium Iodide, 11c-labeled
5. Clidinium Iodide, 3h-labeled
6. Clidinium, 1-(methyl-11c)-labeled
7. Clidinium, 11c-labeled
8. Clidinium, 3h-labeled
9. N-methyl Quinuclidinyl Benzilate
1. 3485-62-9
2. Quarzan
3. Clidinium (bromide)
4. Ro 2-3773
5. Clidinii Bromidum
6. 3-hydroxy-1-methylquinuclidinium Bromide Benzilate
7. Bromuro De Clidinio
8. Bromure De Clidinium
9. Quinuclidinol Methylbromide, Benzilate
10. 1-methyl-3-(benziloyloxy)quinuclidinium Bromide
11. 3-(benziloyloxy)-1-methylquinuclidinium Bromide
12. Nsc-756686
13. 91zqw5jf1z
14. (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide
15. Mls000028560
16. 3-(2,2-diphenyl-2-hydroxyethanoyloxy)-quinuclidinium Bromide
17. Ro-23773
18. (+-)-3-hydroxy-1-methylquinuclidinium Bromide Benzilate
19. Ro-2-3773
20. Dsstox_cid_2835
21. 1-azoniabicyclo[2.2.2]octane, 3-[(hydroxydiphenylacetyl)oxy]-1-methyl-,bromide
22. Dsstox_rid_76750
23. Dsstox_gsid_22835
24. 1-azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-, Bromide
25. 3-{[hydroxy(diphenyl)acetyl]oxy}-1-methyl-1-azoniabicyclo[2.2.2]octane Bromide
26. Smr000058806
27. Clidinii Bromidum [inn-latin]
28. Bromure De Clidinium [inn-french]
29. Bromuro De Clidinio [inn-spanish]
30. Sr-01000000078
31. Einecs 222-471-3
32. Unii-91zqw5jf1z
33. Clidiniumbromide
34. Prestwick_71
35. 1-methyl-3-benzil-oxyloxy-quinuclidinium Bromide
36. Quarzan (tn)
37. Quinuclidinium, 3-hydroxy-1-methyl-, Bromide, Benzilate
38. Clidinium Bromide [usan:usp:inn:ban]
39. Opera_id_114
40. Ncgc00016630-01
41. Cas-3485-62-9
42. Schembl99017
43. Schembl99018
44. Mls001148169
45. Mls002222158
46. Clidinium Bromide (usp/inn)
47. Spectrum1500192
48. Regid_for_cid_19004
49. Clidinium Bromide [mi]
50. Chebi:3744
51. Clidinium Bromide [inn]
52. Chembl1200950
53. Clidinium Bromide [usan]
54. Dtxsid7022835
55. Hms502c20
56. Clidinium Bromide [vandf]
57. Clidinium Bromide [mart.]
58. Hms1570f05
59. Hms1920o15
60. Hms2091e22
61. Hms2097f05
62. Hms2230l12
63. Hms3370h21
64. Hms3714f05
65. Hms3886o06
66. Pharmakon1600-01500192
67. Clidinium Bromide [usp-rs]
68. Clidinium Bromide [who-dd]
69. Hy-b1132
70. Tox21_110535
71. Ccg-38925
72. Nsc756686
73. Akos015895118
74. Tox21_110535_1
75. Clidinium Bromide [orange Book]
76. Cs-4737
77. Ks-1295
78. Nsc 756686
79. (1-methyl-1-azoniabicyclo[2.2.2]octan-8-yl) 2-hydroxy-2,2-diphenylacetate Bromide
80. 1-azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-, Bromide, (+-)-
81. Clidinium Bromide [usp Impurity]
82. Clidinium Bromide [usp Monograph]
83. Ncgc00018171-06
84. Ncgc00094625-01
85. Ncgc00094625-02
86. Ncgc00094625-03
87. Ncgc00094625-04
88. Smr000058806clidinium Bromide
89. Ac-13157
90. Db-048690
91. Ft-0634879
92. D00716
93. D82064
94. A822441
95. J-019784
96. Sr-01000000078-2
97. Sr-01000000078-4
98. Q27106183
99. 3-(2-hydroxy-2,2-diphenylacetoxy)-1-methylquinuclidin-1-iumbromide
100. 3-(2-hydroxy-2,2-diphenylacetoxy)-1-methylquinuclidin-1-ium Bromide
101. (1-methyl-1-azoniabicy-clo[2.2.2]oct-8-yl) 2-hydroxy-2,2-diphenyl-acetate Bro-mide
102. (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-oxidanyl-2,2-diphenyl-ethanoate Bromide
103. 3-(2-hydroxy-2,2-diphenylacetoxy)-1-methyl-1-azoniabicyclo[2.2.2]octane Bromide
104. 1-azoniabicyclo(2.2.2)octane, 3-((2-hydroxy-2,2-diphenylacetyl)oxy)-1-methyl-, Bromide (1:1)
105. 2-hydroxy-2,2-diphenylacetic Acid (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) Ester Bromide
Molecular Weight | 432.3 g/mol |
---|---|
Molecular Formula | C22H26BrNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 431.10961 g/mol |
Monoisotopic Mass | 431.10961 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 482 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24725
Submission : 2011-03-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3659
Submission : 1979-11-15
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-11-18
Pay. Date : 2020-09-18
DMF Number : 35186
Submission : 2020-09-24
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-11-08
Pay. Date : 2017-04-13
DMF Number : 2809
Submission : 1976-12-10
Status : Active
Type : II
NDC Package Code : 17337-0014
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-07-09
Pay. Date : 2019-06-21
DMF Number : 32674
Submission : 2018-03-30
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-14
Written Confirmation Number : WC-0021n
Address of the Firm :
NDC Package Code : 14501-0034
Start Marketing Date : 2018-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0021
Address of the Firm :
NDC Package Code : 14501-0034
Start Marketing Date : 2018-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Clidinium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clidinium, including repackagers and relabelers. The FDA regulates Clidinium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clidinium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clidinium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clidinium supplier is an individual or a company that provides Clidinium active pharmaceutical ingredient (API) or Clidinium finished formulations upon request. The Clidinium suppliers may include Clidinium API manufacturers, exporters, distributors and traders.
click here to find a list of Clidinium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clidinium DMF (Drug Master File) is a document detailing the whole manufacturing process of Clidinium active pharmaceutical ingredient (API) in detail. Different forms of Clidinium DMFs exist exist since differing nations have different regulations, such as Clidinium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clidinium DMF submitted to regulatory agencies in the US is known as a USDMF. Clidinium USDMF includes data on Clidinium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clidinium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clidinium suppliers with USDMF on PharmaCompass.
A Clidinium written confirmation (Clidinium WC) is an official document issued by a regulatory agency to a Clidinium manufacturer, verifying that the manufacturing facility of a Clidinium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clidinium APIs or Clidinium finished pharmaceutical products to another nation, regulatory agencies frequently require a Clidinium WC (written confirmation) as part of the regulatory process.
click here to find a list of Clidinium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clidinium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clidinium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clidinium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clidinium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clidinium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clidinium suppliers with NDC on PharmaCompass.
Clidinium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clidinium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clidinium GMP manufacturer or Clidinium GMP API supplier for your needs.
A Clidinium CoA (Certificate of Analysis) is a formal document that attests to Clidinium's compliance with Clidinium specifications and serves as a tool for batch-level quality control.
Clidinium CoA mostly includes findings from lab analyses of a specific batch. For each Clidinium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clidinium may be tested according to a variety of international standards, such as European Pharmacopoeia (Clidinium EP), Clidinium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clidinium USP).
LOOKING FOR A SUPPLIER?